“…The main reason for such discrepancies lies in the different methods used to define active disease. Owada, et al considered FDG-PET positive for active myositis if muscle FDG uptake was greater than liver uptake, according to the method proposed by Walter, et al to assess activity of large-vessel vasculitis 3 . In contrast, we calculated the ratio of the average FDG proximal muscle to liver maximum standardized uptake values (SUVmax muscle/SUVmax liver) in patients with myositis and controls, respectively, and chose the cutoff value that yielded the best accuracy in discriminating patients from controls.…”